Lee Babiss,Matthew Clark,Anthony D. Keefe,Mark J. Mulvihill,Haihong Ni,Louis Renzetti,Frank Ruebsam,Ce Wang,Zhifeng Xie,Ying Zhang
申请号：
US15300762
公开号：
US20170166568A1
申请日:
2015.04.03
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to compounds according to Formula 1 and pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancer, lymphocyte homing, chronic inflammation, neuropathic pain, fibrotic diseases, thrombosis, and cholestatic pruritus, mediated at least in part by ATX.
